May 3, 2024
“Johnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products caused ovarian cancer, pending approval of the claimants. Those cases… Continue Reading…
April 19, 2024
“House Republicans are prepared to unveil the much-anticipated foreign aid bills on Wednesday, Speaker Mike Johnson told members this morning. Why it matters: The timing sets up weekend votes on bills for foreign aid, national security and the southern border — and… Continue Reading…
April 8, 2024
“Johnson & Johnson on Friday agreed to buy Shockwave Medical for $12.5 billion in a deal that would help broaden its portfolio of medical devices used in treating heart diseases. The acquisition gives J&J access to a device that uses shockwaves to break… Continue Reading…
December 11, 2023
“Johnson & Johnson on Tuesday forecast revenue growth of 5% to 6% for the next year, as it banks on strong demand for cancer treatments Darzalex and Carvykti and resilient sales of blockbuster drug Stelara… The company expects full-year adjusted operational… Continue Reading…
July 24, 2023
“Johnson & Johnson on Monday said it plans to reduce by at least 80% its stake in Kenvue, the consumer health business it spun out as an independent company earlier this year, via a stock exchange offer. J&J owns 89.6% of Kenvue’s common stock, which amounts… Continue Reading…
July 20, 2023
“Johnson & Johnson on Thursday reported second-quarter revenue and adjusted earnings that topped Wall Street’s expectations, and lifted its full-year guidance as sales from the company’s medtech business jumped… That increased demand has been observed by health insurers like UnitedHealth Group and Elevance Health. Here’s how J&J results compared with… Continue Reading…
December 11, 2020
“Amgen (AMGN)… As for the rest of the Street, the results are mixed. Amgen has been assigned 11 Buys, 10 Holds and no Sells. This translates to a Moderate Buy consensus rating. The average price target is $258.18 and represents a… Continue Reading…
July 23, 2020
“1. Walmart Walmart (NYSE:WMT) has a simple formula with a proven long-term success rate. Opening its first discount store nearly six decades ago, the retailer keeps costs low and passes these savings on to its customers. This sounds deceptively easy, but other companies have… Continue Reading…
March 30, 2020
“Stocks rose on Monday, building on a strong rally from last week as the U.S. extends measures to contain the coronavirus outbreak. The S&P 500 climbed 1.6% while the Nasdaq Composite traded 2.1% higher. The Dow Jones Industrial Average was up 237 points, or 1.1%… Sentiment was… Continue Reading…
November 26, 2019
“Dividend stocks might lack the pizzazz of high-growth stocks and appear boring on the surface, but they’re a model of consistency. Income stocks are almost always profitable, they typically have time-tested business models, and they’re the real key to compounding investor… Continue Reading…
Recent Comments